A B S T R A C T Spleen cells from mice immunized with sheep red cells were separated by differential adherence to insolubilized histamine, catecholamines, and prostaglandins. The hormones were insolubilized by linking them to Sepharose beads through a protein carrier. We measured hemolytic plaque formation (per million splenic leukocytes) of cells which passed through columns of hormone-carrier-Sepharose beads (i.e., those cells that failed to bind). As compared with control (no column) cells, the number of plaque-forming cells was substantially reduced by passage through histamine, epinephrine, isoproterenol, and prostaglandin-E2 columns. Plaque-forming cells were not significantly reduced by passage through carrier Sepharose (another control) or norepinephrine-and prostaglandin-F2a-carrier Sepharose columns. Thus, the ability of an insolubilized hormone preparation to subtract plaque-forming cells roughly correlated with the presence of pharmacologic receptors for the corresponding free hormones, as judged by stimulation of cyclic AMP accumulation in the same cells, reported previously. Both 19S and 7S plaqueforming cells were subtracted by columns prepared from pharmacologically active hormones, but none of the insolubilized hormones stimulated accumulation of intracellular cyclic AMP. The cell membrane phenomenon that allows adherence to a given hormone-carrier-bead column may be identical with the cell receptor.
INTRODUCTION
by receptors on a variety of immunocompetent cells (1) (2) (3) (4) (5) . In some of these studies, the hapten or the antigen was insolubilized by covalent linkage to beads of glass, nylon, polyacrylamide, or agarose (Sepharose) (6) (7) (8) (9) . Columns of antigen-Sepharose allowed the cells with receptors to be bound to the immunologic attractant while other cells without receptors passed through the column (6, 7) . We (10, 11) .
A number of studies have demonstrated pharmacologic receptors on leukocytes for histamine, beta-adrenergic catecholamines, and the E-series prostaglandins (PGE)1 (12) (13) (14) (15) . Stimulation of these discrete receptors results in activation of adenyl cyclase and accumulation of cyclic AMP within the cell. Possibly because of increased production of cyclic 3',5'-AMP, there is inhibition of IgE-mediated release of histamine and other mediators of inflammation from human basophils, human and monkey lung, and rat mast cells (14, [16] [17] [18] [19] [20] , inhibition of immunologically specific cytolytic activity ' Abbreviations used in this paper: ECDI, 1-ethyl-3-3 dimethyl aminopropyl carbodiimide; MEM, minimal essential medium; NE(GA)-P-S, norepinephrine linked via glutaraldehyde to polymer and then to Sepharose; NE (GA)-RSA-S, norepinephrine linked via glutaraldehyde to RSA and then to Sepharose; NE-RSA-S, norepinephrine bound via ECDI to RSA and Sepharose; P, polymer of DL-alanine-L-tyrosine, mol wt, 1,800; PBS, 0. 15 (15, 20, 21) , and inhibi tion of release of antibody from leukocytes in vitr( (22) .
We have studied some properties of immunocompetenl cells with "receptors" for endogenous hormones by subtracting them from other splenic leukocytes with insolubilized histamine columns. We found that mouse spleen leukocytes expressing histamine receptors could regulate the magnitude of plaque-forming cell (PFC) response in an adoptive cell transfer (23) . In the present study, a second immunologic function, the release of antibody from lymphocytes, has been assessed by hemolytic plaque formation in agar. The results indicate that a substantial portion of the splenic cells that produce antibodies to sheep red cells (SRC) can be subtracted from the total spleen leukocyte population by columns of insolubilized histamine, beta-catecholamines and the E-series prostaglandins. The PFC are not subtracted by columns made of insolubilized hormones for which there do not seem to be corresponding pharmacologic receptors.
METHODS
Three strains of mice [C57BL/6, BALB/c, and (BALB/c X C57BL/6) F' = BALB/BL] were supplied by the animal breeding house of the Weizmann Institute. The mice were immunized by intraperitoneal injection of 3 X 108 SRC and spleens were removed on day 6, 9, or 13 after immunization. The cells were teased from the spleens, strained through stainless steel mesh (200 mesh), and suspended in Eagle's minimal essential media (MEM), pH 7.4 (Microbiological Associates, Jerusalem). The hemolytic plaque assays were done by a modification of the Jerne, Nordin, and Henry agar plate technique (24, 25) .
The assays were performed in agarose (L'Industrie Biologique Francaise S.A., Gennevilliers, France) on 60-mm plastic disposable Petri dishes (25) . The plates were incubated at 370 for 1 h, and then for an additional h in the presence of 1 ml of 1: 10 diluted lyophilized guinea pig complement (Grand Island Biological Co., Grand Island, N. Y.). Direct PFC were' counted after the 2-h incubation period. Control plates contained between 80 and 150 plaques/ plate. Indirect PFC were developed on the same plates (after the direct PFC had been marked) by incubation for 2 additional h in the presence of 0.1 ml 1:100 diluted rabbit anti-mouse IgG (26) . Triplicate plates were made from each sample and read by two investigators at different times. Rosette formation was assayed by the method of Shearer and Cudkowicz (27) .
Preparation of hormone-Sepharose. Separate batches of histamine, isoproterenol, and PGE1, E2 and F2X were conjugated either to rabbit serum albumin (RSA) or to a synthetic random copolymer (P) of DL-alanine-L-tyrosine (average mol wt of 1,800), by incubating their solutions with 1-ethyl-3-3 dimethyl aminopropyl carbodiimide (ECDI) by methods previously described (10, 11) . The resultant conjugate, RSA, or polymer alone was attached to Sepharose that had been activated by CNBr by the method of Porath, Axen, and Ernback (28) . The details of each preparation and the characterization of the resultant hormone-RSA-Sepharose have been reported elsewhere (11 (Table I ). The high cell to Sepharose ratio and the considerable variability in the effects of different batches of histamine-RSA-Sepharose in part account for the lower mean effect of the columns represented in Table II . In all three experiments tried, the histamine-RSA-Sepharose did not subtract rosetteforming cells from those spleen preparations from which PFC were bound. That the attraction of the insolubilized hormones for the PFC was specific for the hormones and not the carriers is illustrated by: (a) the fact that PFC from the same animal attached to the histamine column but were not bound by RSA-Sepliarose (Table   I) , and (b) in 10 experiments with each of the Seplharose conjugates represented in In order to determine whether the Sepharose preparations were able to subtract PFC equally in various strains of mice, spleen cells from the two parental strains of BALB/BL were studied (Table III) . Rosette-forming cells were not removed by filtration over histamine-RSA-Sepharose in any of the three strains. The pattern of PFC retention by histamine-RSA-Separose was similar in the BALB/c and BALB/BL strains. In contrast, spleen cells from C57BL/6 mice were not bound by any of the Sepharose preparations.
The following characteristics of the hormone-Sepharose preparations were noted: The percentage of decrease of PFC is a function of the ratio of cells to the amount of histamine-RSA-S (Fig. 1) ; as the cell number increased, the inhibition decreased. The columns were maximally effective when 107 cells were incubated with 0.6 ml of the Sepharose preparation, the ratio used to obtain the results in Table I hibited by propranolol (Table IV) Table V. DISCUSSION We have previously demonstrated that the binding of leukocytes to the histamine and NE(GA)-RSA-Sepharose preparations is likely to be dependent primarily on the hormone and seems unrelated to the carrier protein (10, 11) ; the present studies confirm this. They also indicate that at least some cells with receptors to histamine and beta-catecholamines produce antibody. By analogy, it is likely that the PGE2-RSA-Sepharose also binds antibody-forming cells through (11) . The data in the present studies may indi-r cate that some mouse spleen leukocytes have receptors for several biologically active substances. A number of insolubilized hormones attracted PFC, and each substance that bound antibody-forming cells did so with about equal effectiveness. It will be of interest to determine whether the majority of PFC can be removed from the mouse spleen cells by passing those that do not adhere to one insolubilized hormone over a series of columns with other hormones on them.
Additional explanations should be considered: that the average depletion of PFC cells by the columns was only about 50% of the total is probably due in part to the experimental conditions. To obtain an adequate yield of cells from the column within a reasonable time, we had to work at ratios of cells to Sepharose beads that produced submaximal depleting effects (Fig. 1) . With most preparations of histamine-RSA-Sepharose, the cells that were not bound to the columns even under optimal conditions could still respond to histamine and prostaglandin stimuli. Certainly in most experiments not all cells with receptors were removed from the cell mixture. These effects probably indicate that various preparations of hormone-RSA-Sepharose have sufficiently variable molar ratios of amine to RSA to alter their effective affinity for cells that can be attached to the polyvalent attractant (11) , and that morphologically similar cells with specific receptors for a given amine have a spectrum of affinities for the same attractant. In the latter instance, a substantial number of the cells with plaque-forming ability seem to have a high enough affinity for the histamine attractant to be preferentially and selectively removed from the mixture without lowering the total number of cells responsive to either histamine or prostaglandin. In the instances when response to histamine was lowered, so was the response to prostaglandin. Such findings may be consistent with the data in human leukocytes that indicate that receptors for a number of biogenic amines and the prostaglandins may be present on or in the same cell (11) . The data are also consistent with the findings that a number of free hormones prevent plaque formation (22) , and the same hormones can be insolubilized and used to attract PFCs.
The insolubilized hormones attract 7S and 19S PFC equally but the free hormones do not appear to inhibit 7S plaque formation as well as they inhibit 19S (22 (11) . The "real" local concentration of hormone created by a conjugate of the hormone may be many times greater than that created by a similar amount of free hormone per milliliter of suspension. The data in Table III indicate that strain differences may be associated with alterations in the affinity of cells for the insolubilized hormones. However, despite the inability to subtract PFCs from C57BL mouse spleen cells, the cells did respond to free histamine, epinephrine, and PGE2 (22) . They therefore have receptors for the biogenic substances used here. The increase in cyclic AMP content of the C57BL cells and inhibition of plaque formation during such an increase were similar to both such changes obtained in cells from the related strains of mice (22) . The pharmacologic effects of any drug seemed to be equivalent in each strain tested.
The experiments that showed that only some of the PFC capable of responding to free hormone were removed from cell mixtures by histamine-RSA-Sepharose indicate that cells from a given spleen with receptors for the same hormone may have a spectrum of affinity. We cannot determine whether all cells that produce antibody have receptors to the endogenous hormones tested. Neither do we know whether the ability to separate antibody-producing cells on the basis of their hormone receptors is dependent on the antigen used for immunization.
Each hormone-RSA-Sepharose preparation that bound antibody-forming cells was made of hormone agonists for which corresponding leukocytic pharmacologic receptors have been found. Thus histamine, beta-catecholamines (but not alpha-mimetic catecholamines), and the E-series prostaglandins (but not the F-series) increase cellular cyclic AMP (14) and inhibit plaque formation (22 (23) . If the precursor cells to antibody formation had receptors to the amine, we would have expected to retain them on columns of the conjugated hormones. Thus the transfers done with cells excluded from histamine-RSA-Sepharose should have resulted in fewer PFC than controls. Because the enhancement seen in these experiments cannot be accounted for on the basis of cell concentration, we tentatively concluded that receptors for the amines may appear some time after the cell has been committed to production of antibody, i.e., after immunization.
Some mention of the data on rosettes is warranted. One would have expected some binding effect of the hormone-RSA-Sepharose on rosette formers if rosette formers express receptors to SRC antigen, and if some portion of these also are antigen-sensitive cells (30) . There was no effect of the columns on rosette formers. The observation that hormone-Sepharose columns retained PFC but not rosette formers supports other published results whcih suggested that PFC and rosette formers represent distinct populations of immunocompetent cells (25, 30, 31 
